VERICEL CORPORATION Long-Term Debt
VERICEL CORPORATION (VCEL) had Long-Term Debt of $13.18 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2018-11-06
- 2018-09-30: Long-term Debt, Excluding Current Maturities $13.18M.
- 2018-06-30: Long-term Debt, Excluding Current Maturities $14.42M.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $15.65M.
- 2017-12-31: Long-term Debt, Excluding Current Maturities $16.89M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2018-09-30 | $13.18M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $14.42M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $15.65M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $16.89M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $7.40M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $8.04M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.68M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $9.32M 10-Q · filed 2017-11-07 |
| 2016-09-30 | $42.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $52.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $62.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $71.00K 10-Q · filed 2016-11-07 |
| 2015-09-30 | $81.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $91.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $100.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $109.00K 10-Q · filed 2015-11-13 |
| 2014-09-30 | $115.00K 10-Q · filed 2014-11-13 |
| 2013-03-31 | $2.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $6.00K 10-K · filed 2014-03-13 |
| 2012-09-30 | $9.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $19.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $29.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $40.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $49.00K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $43.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $41.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |